This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Google Scholar Articles by Attal, P. Articles by Chanson, P. PubMed PubMed Citation Articles by Attal, P. Articles by Chanson, P. Related Collections Neuroendocrinology and Pituitary Cardiovascular Endocrinology Obesity

Endocrine Aspects of Obstructive Sleep Apnea

Assistance Publique-Hôpitaux de Paris, Hôpital de Bicêtre, Service d’Oto-Rhino-Laryngologie (P.A.), and Service d’Endocrinologie et des Maladies de la Reproduction (P.C.), Le Kremlin-Bicêtre F-94275, France; and Université Paris-Sud 11 (P.A., P.C.), Faculté de Médecine Paris-Sud, and Institut National de la Santé et de la Recherche Médicale (P.C.), Unité 693, Le Kremlin-Bicêtre F-94276, France

Address all correspondence and requests for reprints to: Prof. Philippe Chanson, Service d’Endocrinologie et des Maladies de la Reproduction, Hôpital de Bicêtre, F-94275 Le Kremlin-Bicêtre, France. E-mail: philippe.chanson{at}bct.aphp.fr.

Context: Some endocrine and metabolic disorders are associated with a high frequency of obstructive sleep apnea (OSA), and treatment of the underlying endocrine disorder can improve and occasionally cure OSA. On the other hand, epidemiological and interventional studies suggest that OSA increases the cardiovascular risk, and a link between OSA and glucose metabolism has been suggested, via reduced sleep duration and/or quality.

Evidence Acquisition: We reviewed the medical literature for key articles through June 2009.

Evidence Synthesis: Some endocrine and metabolic conditions (obesity, acromegaly, hypothyroidism, polycystic ovary disease, etc.) can be associated with OSA. The pathophysiological mechanisms of OSA in these cases are reviewed. In rare instances, OSA may be improved or even cured by treatment of underlying endocrine disorders: this is the case of hypothyroidism and acromegaly, situations in which OSA is mainly related to upper airways narrowing due to reversible thickening of the pharyngeal walls. However, when irreversible skeletal defects and/or obesity are present, OSA may persist despite treatment of endocrine disorders and may thus require complementary therapy. This is also frequently the case in patients with obesity, even after substantial weight reduction.

Conclusions: Given the potential neurocognitive consequences and increased cardiovascular risk associated with OSA, specific therapy such as continuous positive airway pressure is recommended if OSA persists despite effective treatment of its potential endocrine and metabolic causes.

"Apropos of sleep, that sinister adventure of all our nights, we might say that men go to bed daily with an audacity that would be incomprehensible if we did not know that it is the result of ignorance of the danger."

Charles Baudelaire, in "Fusées, IX"